SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Interpace Biosciences Announces Third Quarter 2026 Financial and Business Results

Q3 Revenue of $10.4 million Q3 Thyroid volume year-over-year increase of 7% Q3 Thyroid revenue year

IDXG

Related stories